Market Leaders - Stem Cell Therapy Market
The stem cell therapy market is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period. Increased research funding for stem cell research coupled with huge number of candidates under clinical pipeline studies are some of the major factors propelling the stem cell therapy market growth.
The global stem cell therapy market is highly competitive. The prominent players operating in this market include Smith+Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), CORESTEM (South Korea), Pharmicell Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), and among others
To know about the assumptions considered for the study download the pdf brochure
Smith+Nephew (UK)
Smith+Nephew serves to the stem cell therapy market through its advanced wound management business segment. Allogeneic stem cell therapies such as Bio4 (musculoskeletal disorders), Grafix, and Stravix (treatment of wounds & injuries) are some of the products offered by the company. Smith+Nephew has direct & indirect presence across different regions across the globe. The company has strong emphasis on product development and commercialization of stem cell therapies in order to retain market position.
MEDIPOST Co., Ltd. (South Korea)
MEDIPOST Co., Ltd. has a strong market presence in the Asia Pacific region. The company offers stem cell therapy products for various disease conditions such as musculoskeletal disorders. MEDIPOST Co., Ltd. has strong emphasis on organic growth strategies & Inorganic growth stratergies. Additionally, the company has strong focus on development and commercialization of stem cell therapy candidates in pipeline. Therapeutic applications such as neurological disorders and pulmonary ailments are two of the key areas of investments through which the company is expected to expand its share on the stem cell therapy market.
Related Reports:
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
